Last week, I was at ELRIGfr meeting in Monaco, as president of RA’pro (Association for the Promotion of Augmented Reality), to chair an augmented reality workshop with famous societies as Molecular Devices, Sopra Steria, agence dad and Microtechnix.  Many other things were of course interesting and, even if I’m not a biologist, I’m happy to share my impressions with you !

First day was dedicated to precision medicine and data management. Yves Colette talked about the importance molecular biology in personalized medicine. The genetic approach is not enough and high throughput ex vivo tests could open new therapeutic strategies. Later, Jean François Deleuze ( Head of Centre National de Recherche en Génomique Humaine at CEA) came to present us the explosion of use of NGS technologies and to give new informations about the French Plan for Genomic Medicine 2025. The first two platforms will be launched soon : SeQOIA (Ile-de-France, led by AP-HP Paris Public Hospitals Network, as well as the Curie and Gustave Roussy Institutes) and AURAGEN (based in Auvergne-Rhône Alpes,  led by the region’s four CHUs, two Regional Comprehensive Cancer Centers (CRLCCs), and the Loire Oncology Institute).

Data management session showed us the complexity of a real integrated IT system for a pharmaceutical or biotech company. Many applicative components are available today but interoperability seems not be be considered seriously by editors … Marie-Pierre Fialon (Evotech) gave us an very interesting view of how Evotech has implemented tools to share data between research teams.

Second day was dedicated to lab automation and, to be honest, it was hard for me to understand all discussions 🙂 But I noticed the feedback of Jonathan Pascau (Galderma) about the use of 1536 plates in cell based assays. The miniaturisation of these kinds of assays is not so simple but, when difficulties are overwhelmed, benefices are really important ! It’s exactly what we are doing now in HCS Pharma 🙂 The presentation of Phillippe Hartz (Roche) was also very interesting because he talked about the implementation of phenotypic screening under BLS-3 conditions !

Augmented Reality workshop ELRIGfr 2017 Monaco

And the last event was the! I was very please to organize such a event with amazing use cases :

  • Yoann Yvon et Antoine Godin from Sopra Steria explained the usefulness of “digital twin” in industries. They showed us how to use it in our field to increase efficiency
  • Olivier Lefevre (agence dad) illustrated the use or augmented reality in “everyday life” of a company, from products conception to virtual showcases on a communication events. He explained his work with Cedric Point from Molecular Devices for the installation of our platform HAPIX.
  • Wouter Christiansens (Microtechnix) presented his “virtual ScanLab II” which help you to test functionalities of this device with a HTC Vive Helmet. You are completely immerged in a virtual laboratory where you can manipulate the ScanLab II. A very useful experience !

See you next year in Strasbourg for another exiting ELRIGfr event !

The next ELRIGfr meeting will take place in Monaco (November 27th and 28th) and our CDO, Grégory MAUBON, will organize a special session about the use of augmented and virtual reality in laboratories.

After a first “step” during last ELRIGfr event (Forum Labo Paris) where many possibilities were presented, it’s time now to look at real cases. Grégory, who is also president of RA’pro (Association for the Promotion of Augmented Reality), has chosen three uses with clear results :

  • Sopra Steria will present how to use 3D models in training and quality control with augmented reality
  • Agence dad and Molecular Devices will present how augmented reality could be used in laboratories for devices integration and training. Of course, we will talk about our use of augmented reality for our HAPIx installation !
  • MicroTechniX will present their use of virtual reality for ScanLab II, where you can test the equipment remotely and before the machine is built!

Of course, many other interesting things will be discussed during these two days, like personalized medicine and data management ! We will be happy to meet you in Monaco !

If you have any questions about integration of immersive technologies in biotechnologies, pharmaceutical industries (and even in other fields), feel free to contact Grégory !

13th and 14th October 2016,  drug discovery 2016 was held in Liverpool, UK. We really enjoyed our venue at the 10th anniversary of ELRIG drug discovery symposium. Thanks to the ELRIG organisaters, we had the chance to present our activities in the innovation zone. A lot of exchanges were made about implementation of cellular high content assays across pharma, biotech, and academic research activities. We hope all these talks will lead to business and scientific collaborations.

High quality scientific presentations and posters made this symposium scientifically rewarding for drug discovery. Plennary sessions on translationnal and predictive models were very interesting. Advances in microstissues screening for drug prediction presented by Paul Walker highlight that 3D culture open a new area in high content analysis and  reinforces our choices in our R&D activities.

We would like to thank all the visitors who came to our booth, and we hope to meet you again next year !

 

We were proud to co-organize the previous ELRIGfr event in Rennes. 140 people attented this meeting, which was rich in presentations and exchanges during workshops and round tables about automation and innovation. We had the opportunity to attend two of these workshops:

 – A first one on pipeting calibration for robotic platform. A lot of things need to be done to harmonize and/or standardise this calibration. That would for example be the implementation of a working group within ELRIGfr that would propose a specific regulation (as it was done for single-channel pipettors).

– We also attend to the workshop on Robotic Liquid Handling (RLH) during which Pascal SILVERSMET from GSK Vaccines exposed the interest in implementing a management software for robotic plateforms. A flexible model in the form of bricks with a web-based interface, enabling automatic machine-warnings in one hand (in order to facilitate the maintenance of the park) and the use of their platform by many teams in the other hand (a scheduling tool with different levels of accreditation), seemed to interest the assembly.

Speakers, as Jean-Philippe Stephan from Servier or Anselme Perrier from ISTEM, exposed us their use of innovative technology (HCS, IPS, …) in a really interesting manner in their company. It was really interesting to have their impression on all these new technologies.

All presentations are avalaible under this link

We also wanted to thank Mme Gaëlle ANDRO, vice-president of Rennes Métropole for her support and her talk of introduction during this event !

This slideshow requires JavaScript.

 

We are very proud to contribuate to organize next ELRIGfr event in Rennes. The central topic will be “Lab Automation, Formulation & Phenotypic screening” explored during three sessions :

  • Drug discovery by phenotypic screening
  • Automation of innovative cellular models
  • Automation of formulation & physchem

For each session, round table will be organized to exchange on the different processes in pharmacology, cosmetology and agronomy field. Find the complete program and inscription form on this link.

Of course, it will be a good opportunity for us to show the dynamism of “Rennes Metropole” in the support of biotech companies ! We will also talk about links between biotech and digital.

See you in Rennes !

 

We will be present in the “innovation zone” during the Drug discovery 2015 in Telford the 2nd and 3rd of September. The event is organised by ELRIG into 8 scientific sessions, which one is on phenotypic discovery and cell imaging. For participants, this event is free of charge. Thus, come and see us in the innovation zone!
If you want more detail about this event, follow this link: http://elrig.org/portfolio/drug-discovery-2015/

I was really impressed by the size and quality of the Drug Discovery 2014 organised by ELRIG in Manchester. More than 1,500 scientists participated in this meeting and nearly 100 exhibitors were present. Phentoypic screening and high content screening were prominent in this conference and we could hear researchers from Roche, Astrazeneca, Merck Serono or Cancer research UK / UK-NPSC (National Screening Phentypic center) to explain us how they have implemented phenotypic screening and HCA / HCS in their lab and process of drug discovery.
Here, you can hear an interesting interview from Dr. Peter Simpson, Co-Organizer of Elrig Drug Discovery 2014, directed by SelectScience :

Dr. Peter Simpson Discusses ELRIG Drug Discovery 2014

Dr. Peter Simpson Discusses ELRIG Drug Discovery 2014

Come and joins us to the congress organised by ELRIG: drug discovery 2014. A specific new session on phenotypic discovery and cellular imaging will be implemented in the 2014 programm.

I you want to learn more about this congress and to register, follow this link!

We are pleased to see you soon in Manchester!

 

%d bloggers like this: